Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2016-10-31
2017-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PERFECT Project - Part 2 - Study 1
NCT02402517
Evaluation of the Effects of a Novel Dietary Microalgae Based Ingredient on Muscle Recovery and Endurance Capacity
NCT05760742
Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function and Cognition in CKD
NCT03689569
Strong Women Study
NCT01476033
The Effects of 10 Days of Extreme Endurance on Performance
NCT03337737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bagel control
100% wheat flour
Control
Non pulse ingredient bagel
Bagel with pea flour
Pea flour (30%)
Pea flour
Pulse ingredient bagel
Bagel with pea fibre
Pea fibre (11g)
Pea fibre
Pulse ingredient bagel
Bagel w/ pea flour + pea fibre
Pea flour (30%) + pea fibre (11g)
Pea flour and pea fibre
Pulse ingredient bagel
Bagel w/ pea flour + pea protein
Pea flour (30%) + pea protein (24g)
Pea flour and pea protein
Pulse ingredient bagel
Bagel w/ pea flour + pea fibre + pea protein
Pea flour (30%) + pea fibre (11g) + pea protein (24g)
Pea flour + pea fibre + pea protein
Pulse ingredient bagel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control
Non pulse ingredient bagel
Pea flour
Pulse ingredient bagel
Pea fibre
Pulse ingredient bagel
Pea flour and pea fibre
Pulse ingredient bagel
Pea flour and pea protein
Pulse ingredient bagel
Pea flour + pea fibre + pea protein
Pulse ingredient bagel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Regularly skip breakfast
* Smokers
* Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity)
* Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year
* Those unable to walk for an hour continuously
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saskatchewan Pulse Growers
OTHER
Alberta Pulse Growers
OTHER
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter JH Jones, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2014:114-6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.